StockData
Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd. (NNOX) company profile

NNOXNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Apr 30, 2026Score 5/30
$0.29−0.03 (-10.24%)

Close on Nov 17, 2026Market cap $20.01MP/E –Yield –

About Nano-X Imaging

X-Ray Apparatus & Tubes & Related Irradiation Apparatus, SIC 3844

Nano-X Imaging Ltd. is an initial launch-stage medical imaging technology company that develops and commercializes digital X-ray source technology. Its primary products include the Nanox.ARC and Nanox.ARC X, which are multi-source 3D digital tomosynthesis systems, alongside the cloud-based Nanox.CLOUD platform. The company also provides teleradiology services and artificial intelligence image-analysis decision-support solutions. Nanox pursues three commercial business models: a subscription-based pay-per-scan medical screening service, direct equipment capital sales, and original equipment manufacturer licensing. Its target customers and users include physicians, diagnostic testing centers, medical imaging providers, hospitals, urgent care operators, and large healthcare systems.

The company operates internationally, having deployed dozens of systems for clinical, commercial, and demonstration purposes across multiple states in the United States as well as in other countries. It utilizes third-party manufacturing partners located in Israel and Singapore to support hardware production. Nano-X Imaging Ltd. is incorporated under the laws of the State of Israel, with its principal executive offices located in Petach Tikva, Israel.

Summary of the business section of Nano-X Imaging's latest annual report, written by StockData.

Company profile

Company

Legal name
Nano-X Imaging Ltd.
Founded
2018
Headquarters
Petach Tikva, L3
Address
Ofer Tech Park, 94 Shlomo Shmeltzer Road 4970602
Phone
972-37359202
Employees
197, Dec 31, 2025
Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Incorporated in
L3
Fiscal year ends
December 31
Auditor
Kesselman & Kesselman, Tel Aviv

Stock & identifiers

Ticker
NNOX
Exchange
Nasdaq
IPO date
Aug 24, 2020
Shares outstanding
70M, Dec 31, 2025
Filer category
Accelerated filer
SEC CIK
1795251
CUSIP
M70700105
FIGI
BBG00RDSZ6J2
Share class FIGI
BBG00RDSZ6K0
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Erez MeltzerChief Executive Officer, Director151,027
sharon sabanGeneral Manager AI Division28,283
Feler Marina GofmanChief Legal Officer28,283
Attias Gali YahavChief Corporate Resources28,283
Guy NathansohnChief Financial Officer50,000
Cohen Tamar AharonEVP & Chief Marketing Officer28,283
Ofir KorenGeneral Manager, ARC Division28,283
James DaraGM Source & Services Division28,283
Ran DanielCFO5,950
Dan S. SuesskindDirector110,000
Noga KainanDirector41,586
Erez AlroyDirector17,075
Nehama RonenDirector7,792
Michael JackmanDirector7,793

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Aug 24, 2020
Offer price
$18.00
Exchange
Nasdaq
First trading day
Aug 21, 2020
First-day close
$21.70+20.6%
Lock-up ends (est.)
Feb 17, 2021

“The initial public offering price is $18.00 per ordinary share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 197 employees, of which 114 employees”

Corporate history

Events identified from SEC filings

See a number that looks wrong?